Geron Corporation

Company Profile

Geron Corporation had its IPO on 1996-06-30 under the ticker symbol GERN.

The company operates in the Healthcare sector and Biotechnology industry. Geron Corporation has a staff strength of 107 employees.

Stock update

Shares of Geron Corporation opened at $2.59 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.25 - $2.66, and closed at $2.3.

This is a -1.71% slip from the previous day's closing price.

A total volume of 18,470,929 shares were traded at the close of the day’s session.

In the last one week, shares of Geron Corporation have slipped by -7.26%.

Geron Corporation's Key Ratios

Geron Corporation has a market cap of $1.22 billion, indicating a price to book ratio of 8.2822 and a price to sales ratio of 571.9769.

In the last 12-months Geron Corporation’s revenue was $450000 with a gross profit of $-93668000 and an EBITDA of $-173563008. The EBITDA ratio measures Geron Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Geron Corporation’s operating margin was -38653.78% while its return on assets stood at -33.27% with a return of equity of -77.66%.

In Q2, Geron Corporation’s quarterly earnings growth was a positive 0% while revenue growth was a negative 60.3%.

Geron Corporation’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

-2.38

Its diluted EPS in the last 12-months stands at $-0.37 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of -2.38. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Geron Corporation’s profitability.

Geron Corporation stock is trading at a EV to sales ratio of 493.5541 and a EV to EBITDA ratio of -6.0818. Its price to sales ratio in the trailing 12-months stood at 571.9769.

Geron Corporation stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$415.30 million

Total Liabilities

$72.57 million

Operating Cash Flow

$0

Capital Expenditure

$202000

Dividend Payout Ratio

0%

Geron Corporation ended 2025 with $415.30 million in total assets and $0 in total liabilities. Its intangible assets were valued at $415.30 million while shareholder equity stood at $298.43 million.

Geron Corporation ended 2025 with $0 in deferred long-term liabilities, $72.57 million in other current liabilities, 522000.00 in common stock, $-1500991000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $56.90 million and cash and short-term investments were $371.38 million. The company’s total short-term debt was $11,628,000 while long-term debt stood at $40.80 million.

Geron Corporation’s total current assets stands at $377.28 million while long-term investments were $28.28 million and short-term investments were $314.48 million. Its net receivables were $1.19 million compared to accounts payable of $7.67 million and inventory worth $535000.00.

In 2025, Geron Corporation's operating cash flow was $0 while its capital expenditure stood at $202000.

Comparatively, Geron Corporation paid $0 in dividends in 2025.

Other key metrics

Current Trading Price

$2.3

52-Week High

$3.84

52-Week Low

$1.95

Analyst Target Price

$4.83

Geron Corporation stock is currently trading at $2.3 per share. It touched a 52-week high of $3.84 and a 52-week low of $3.84. Analysts tracking the stock have a 12-month average target price of $4.83.

Its 50-day moving average was $2.85 and 200-day moving average was $2.77 The short ratio stood at 8.58 indicating a short percent outstanding of 0%.

Around 13% of the company’s stock are held by insiders while 6459.6% are held by institutions.